Merck (MRK) Wins FDA Approval For WELIREG Plus LENVIMA In Kidney Cancer
Merck (NYSE:MRK) reported FDA approval of WELIREG plus LENVIMA for adults with advanced renal cell carcinoma after prior PD-1 ...
Is Halozyme’s EU Injunction on Subcutaneous Keytruda Reshaping the Investment Case For Merck (MRK)?
In late September 2026, a Dutch court ruled in favor of Halozyme Therapeutics, issuing an injunction that halts manufacture ...
Halozyme Wins Injunction Against Merck in Keytruda Patent Case -- Update
The specialized Dutch patent court of the Hague found Merck to be infringing upon one of Halozyme's patents, ordering Merck to refrain from manufacturing and selling Keytruda SC in Belgium, Denmark, ...
Halozyme Granted Another Injunction Against Merck in Keytruda Patent Case
Halozyme previously sued Merck in Germany, and the company said it was granted a preliminary injunction late last year to stop the launch of Keytruda SC in the country. Halozyme has also sued Merck ...
AI companies run virtual drug trials, aim to improve success of human studies
Novartis’ experimental del-desiran for a rare type of muscular dystrophy was expected to be a winner, with the Swiss company's CEO predicting annual peak sales of $5 ...